Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    22315276 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting anti10a Levels in Women Treated With LMWH in the Postpartum Period
Condition: Venous Thromboembolism
Intervention: Drug: clexane (LMWH)
2 Recruiting Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial
Conditions: Thrombophilia Associated With Pregnancy;   Perioperative/Postoperative Complications;   Venous Thrombosis;   Pulmonary Embolism;   Other Specified Risk Factors in Pregnancy;   Deep Vein Thrombosis
Interventions: Drug: Enoxaparin;   Other: No intervention
3 Recruiting Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
Conditions: Deep Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Low dose nadroparin;   Drug: Intermediate dose nadroparin;   Drug: Low dose enoxaparin;   Drug: Intermediate dose enoxaparin;   Drug: Low dose dalteparin;   Drug: Intermediate dose dalteparin;   Drug: Fixed low dose tinzaparin;   Drug: Intermediate dose tinzaparin

Indicates status has not been verified in more than two years